Monthly Archives: July 2014

To Tweet or Not to Tweet? Or Even Retweet? FDA, Tweeting and Twitter

Posted on July 31, 2014 by Mark Senak

On June 27, FDA approved a new product – a rapid acting inhaled insulin indicated for the treatment of diabetes call Afrezza.  The agency announced the approval by sending out a press release.  The agency also sent out this tweet: … Continue reading →

Posted in Social Media | 2 Comments

Upcoming AdComms By Subject Matter

Posted on July 28, 2014 by Mark Senak

In February and in April I posted a listing of upcoming advisory committees by subject matter and people seemed to like this way of looking at it, so I try to repeat it every so often.  Today is every so … Continue reading →

Posted in Advisory Committee Prepapartion | Comments Off on Upcoming AdComms By Subject Matter

Weekly Roundup 7.25.14

Posted on July 25, 2014 by Mark Senak

We sit on the cusp of August – the month when America goes on vacation.  Everything will slow down, rush hour will be less rushed, lawns will need less cutting and in our sights is Labor Day which brings the … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 7.25.14

Developing a Policy for Correcting Third Party Misinformation

Posted on July 22, 2014 by Mark Senak

Last week I held my Webinar on FDA’s Regulation of Social Media called “In More than 140 Characters…”  During the 1 hour presentation, I attempted to cover a lot of ground, wanting not only to focus on the latest two … Continue reading →

Posted in Social Media | Comments Off on Developing a Policy for Correcting Third Party Misinformation

Weekly Roundup 7.18.14

Posted on July 18, 2014 by Mark Senak

Well, the “poor man’s polar vortex blew through and frankly, while it did make life overall more bearable.  But the dogs, the lawn and the flowers all seem happier so that makes it ok by me.  I also had my … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 7.18.14